Company news
Pathkey.AI Limited news in 2024
Pathkey.AI Limited's news releases, calls and decks from 2024, newest first.
OPL Signs Partnership Agreement with NeuOrphan
December 10, 2024
OPL Partners L39 Capital to Launch AI-Powered Biotech Fund
December 9, 2024
OPL Signs Service Agreement with Southern CDC
November 20, 2024
Updated Quarterly Activities & Cashflow Report
October 29, 2024
Opyl Signs New Service Agreement with Commercial Eyes
October 15, 2024
Opyl Signs New Service Agreement with Biointelect
September 24, 2024
Strategic Partnership with Phenix Health Compendium Platform
September 22, 2024
Opyl Enters Strategic Partnership with Alithia Life Sciences
September 16, 2024
Opyl - Full Year Results
August 29, 2024
Opyl - Appendix 4E
August 29, 2024
Opyl Secures $700K loans to advance TrialKey & Drive Growth
August 21, 2024
Opyl - Business Update & Appendix 4C
July 30, 2024
OPL signs MOU for EMEA & US Expansion
July 23, 2024
Opyl Partners with L39 Capital to Launch AI Biotech Fund
July 8, 2024
Opyl Announces First Trial Gen Revenue & Customer
June 5, 2024
Opyl signs binding agreement for sale of Opin business
April 22, 2024
Reinstatement to Quotation
March 22, 2024
Opyl receives non-binding offer for its Opin business
March 22, 2024
Suspension from Quotation
March 21, 2024
Request for Trading Halt
March 20, 2024
Pause in Trading
March 20, 2024
Successful Placement of Rights Issue Shortfall
February 7, 2024
Opin Signs New $282K Patient Recruitment Contract
February 4, 2024